Autism Diagnosed at 12 to 36 Months Does Not Always Persist
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
WEDNESDAY, Oct. 18, 2023 -- More than one-third of children clinically diagnosed with autism spectrum disorder (ASD) at 12 to 36 months of age do not continue to meet the diagnostic criteria at age 5 to 7 years, according to a study published online Oct. 2 in JAMA Pediatrics.
In a natural history cohort study, Elizabeth Harstad, M.D., M.P.H., from Boston Children's Hospital, and colleagues examined the frequency with which children who are clinically diagnosed with ASD at 12 to 36 months of age continue to meet diagnostic criteria for ASD at age 5 to 7 years.
The researchers found that 37.1 percent of the 213 participants diagnosed with ASD at initial clinical assessment did not continue to meet diagnostic criteria for ASD (nonpersistent ASD) at research assessment (mean age, 74.3 months). Children with nonpersistent ASD had an IQ of at least 70, while those with persistent ASD had a bimodal distribution of IQ (46 with IQ <70; 88 with IQ ≥70). Some interventions were received by all children; 94.4 percent received an ASD-specific intervention, which was mainly applied behavioral analysis. Higher baseline adaptive skills and female sex were the only variables associated with increased odds of being in the nonpersistent ASD group at 6 years of age.
"Our research shows how important it is that we monitor kids over time, because some children may really have changes in their social communication and behavioral function," Harstad said in a statement. "This underscores the need for continuous assessments and adaptable intervention strategies."
One author disclosed ties to Understood.org.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted October 2023
Read this next
Prenatal Opioid Exposure Not Tied to Neuropsychiatric Disorders in Offspring
THURSDAY, April 25, 2024 -- Prenatal opioid exposure seems not to be associated with a meaningful increase in the risk for neuropsychiatric disorders in offspring, according to a...
Dialectical Behavior Therapy Reduces Suicidal Behavior in Adults With Autism
MONDAY, April 22, 2024 -- Dialectical behavior therapy (DBT) is safe and shows short-term efficacy in reducing suicidal ideation and suicide attempts in adults with suicidal...
Heritability for Autism Spectrum Disorder Varies for Males and Females
WEDNESDAY, April 17, 2024 -- Heritability for autism spectrum disorder (ASD) varies for males and females, with higher heritability seen for males than females, according to a...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.